Skip to main content

Bastone Bronwen's Form 4 filing

Enfusion, Inc.ENFN · filed Jun 21, 2024

Accession no.
0001104659-24-074024
Filed
Jun 21, 2024
Trade date
Jun 18-20, 2024
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market sales total $234.0K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bastone BronwenCIK 0001927636Officer (Chief People Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 18, 2024Class A Common StockSSaleDisposed−10,539$8.17F2−$86,103.63217,154Direct
Jun 20, 2024Class A Common StockSSaleDisposed−18,241$8.11F3−$147,934.51198,913Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.06 to $8.28. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.02 to $8.17. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)